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Vibrio cholerae is an aquatic bacterium that causes the severe diarrheal disease cholera. V. cholerae strains
of the O1 serogroup exist as two biotypes, classical and El Tor. Toxigenic strains of the El Tor biotype emerged
to cause the seventh pandemic of cholera in 1961 and subsequently displaced strains of the classical biotype
both in the environment and as a cause of cholera within a decade. The factors that drove emergence of the El
Tor biotype and the displacement of the classical biotype are unknown. Here, we show a unique difference in
carbohydrate metabolism between these two biotypes. When grown with added carbohydrates, classical biotype
strains generated a sharp decrease in medium pH, resulting in loss of viability. However, growth of El Tor
biotype strain N16961 was enhanced due to its ability to produce 2,3-butanediol, a neutral fermentation end
product, and suppress the accumulation of organic acids. An N16961 mutant (SSY01) defective in 2,3-
butanediol synthesis showed the same defect in growth that classical biotype strains show in media rich in
carbohydrates. Importantly, the SSY01 mutant was attenuated in its ability to colonize the intestines of infant
mice, suggesting that host carbohydrates may be available to V. cholerae within the intestinal environment.
Similarly, the SSY01 mutant failed to develop biofilms when utilizing N-acetyl-D-glucosamine as a carbon
source. Because growth on N-acetyl-D-glucosamine likely reflects the ability of a strain to grow on chitin in
certain aquatic environments, we conclude that the strains of classical biotype are likely defective compared to
those of El Tor in growth in any environmental niche that is rich in chitin and/or other metabolizable
carbohydrates. We propose that the ability to metabolize sugars without production of acid by-products might
account for the improved evolutionary fitness of the V. cholerae El Tor biotype compared to that of the classical
biotype both as a global cause of cholera and as an environmental organism.
Toxigenic strains of Vibrio cholerae can cause cholera.
Strains that display two serogroups, O1 and O139, typically
cause epidemic and endemic disease. O1 strains can be further
classified into two biotypes, termed classical and El Tor. The
first six pandemics of cholera were caused by classical biotype
strains, and the current, seventh pandemic is caused by a
closely related group of the El Tor biotype. The seventh-pan-
demic El Tor O1 “clone” emerged in 1961 in Indonesia. How-
ever, within a decade this highly successful clone displaced all
classical strains as a cause of cholera throughout areas of the
world where cholera is endemic. The seventh-pandemic El Tor
clone is also remarkable in that it has established endemicity in
virtually every area of the world where it has been introduced,
including Africa and Latin America. Most recently, strains of
the O139 serogroup have emerged to also cause cholera in
southern Asia (4, 51). These strains are clearly derived from
the seventh-pandemic El Tor O1 clone and now coexist with
O1 El Tor strains in locations of cholera endemicity, such as
India and Bangladesh (44).
Epidemics caused by strains of the El Tor biotype produce a
lower case fatality rate and a higher incidence of asymptomatic
infections than those caused by strains of the classical biotype
(26). To date, several biotype-specific biochemical features,
including (i) hemolysis (1, 41), (ii) hemagglutination of chicken
erythrocytes (19), (iii) resistance to polymyxin B (37), (iv)
bacteriophage-mediated lysis (30, 49), and (v) acetoin synthesis
(21, 27), have been used to distinguish strains of the El Tor
biotype from those of the classical biotype. Among these, acet-
oin biosynthesis has been used most widely for biotyping.
Seventh-pandemic O1 El Tor strains and all strains of the
O139 serogroup are positive in this assay, while classical strains
are not. The molecular basis, however, that accounts for the
negative test result for classical O1 V. cholerae is not under-
stood.
In addition to the aforementioned differences in biochemical
traits, comparative DNA analyses revealed differences in the
gene contents (8) and polymorphic sequence variations in sev-
eral regions of the genome, including loci responsible for the
production of virulence factors in these two biotypes. Biotype-
specific DNA sequence differences in the gene encoding TcpA,
a structural component of toxin-coregulated pilus, have been
used to differentiate El Tor strains and classical strains by
simply comparing the sizes of PCR products (23, 50). Single-
base-pair differences in the tcpPH promoter region were also
found and proposed to be responsible for the differential reg-
ulation of virulence gene expression in these two biotype
strains (28, 36). Recently, two genes in the tRNA operon 1
were reported to be missing in the classical biotype compared
to El Tor (11). Each strain also requires different culture con-
ditions to produce cholera toxin (CT), the major virulence
determinant of V. cholerae. CT can be produced in classical
strains growing under mildly acidic conditions Luria-Bertani
(LB), 30°C, pH 6.5). In contrast, CT production from El Tor
strains is efficient only under unusual biphasic growth condi-
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tions typically referred to as AKI conditions (7, 15). Based on
the aforementioned studies, it was suggested that classical and
El Tor biotypes may have evolved independently from different
lineages (11, 22).
In this study, we identified a dramatic difference in carbo-
hydrate metabolism between strains of the classical and El Tor
biotypes. This difference leads classical biotype strains to pro-
duce organic acids when metabolizing carbohydrates, with a
concomitant drop in pH of the growth media. Because V.
cholerae is a profoundly acid-sensitive organism, this drop in
pH rapidly inhibits further growth of strains of classical biotype
on carbohydrate-rich media. El Tor strains do not accumulate
such acids but instead produce 2,3-butanediol as their fermen-
tation end product and thus grow to much higher densities in
media containing carbohydrates. A mutant of an El Tor bio-
type strain deficient in the 2,3-butanediol fermentation showed
the same growth defect displayed by classical biotype strains
under carbohydrate-rich conditions. Thus, El Tor biotype
strains which produce 2,3-butanediol are predicted to have a
profound selective advantage over classical biotype strains in
any environment that is rich in metabolizable carbohydrates.
Such a metabolic selection can explain the dramatically im-
proved fitness of toxigenic El Tor compared to the earlier
classical biotype strains. We provide evidence here that this
metabolic selection might have occurred both within the hu-
man host and in carbohydrate-rich aquatic environments.
MATERIALS AND METHODS
Bacterial strains and culture conditions. All strains and plasmids used in this
study are listed in Table 1. Bacterial cultures were grown at 37°C in LB (10 g
tryptone, 5 g NaCl, and 5 g yeast extract per liter) with shaking unless otherwise
noted. The antibiotics streptomycin (200 g/ml for V. cholerae), kanamycin (100
g/ml for V. cholerae and 50 g/ml for Escherichia coli), ampicillin (100 g/ml for
E. coli), and chloramphenicol (10 g/ml for E. coli) were used as required.
In-frame deletion mutants of ald (VC1589) and VC1591 were constructed fol-
lowing a gene replacement procedure involving sucrose counterselection (46).
Phenol red (20 mg/liter; Sigma Chemical Co., St. Louis, MO) was added in pH
indicator plates.
Transposon mutagenesis and identification of genes interrupted by transpo-
son insertions. A library of random transposon insertion mutants was con-
structed by introducing TnKGL3, a mariner-based transposon, into V. cholerae
recipient strains through conjugation. TnKGL3 was derived from TnTGL3 (42)
by replacing the Tetr cassette with a Kmr cassette. Kmr transconjugants were
obtained by biparental matings (5) and screened for a mutant that acidified the
culture medium in the presence of glucose. An arbitrary PCR was performed to
determine the location of the TnKGL3 insertion site in each mutant. It was first
performed using a transposon-specific primer, Mar1 (5-GGGAATCATTTGA
AGGTTGGT-3), and two random primers, Arb1 (5-GGCCACGCGTCGAC
TAGTACNNNNNNNNNNGATAT-3) and Arb6 (5-GGCCACGCGTCGAC
TAGTACNNNNNNNNNNACGCC-3), and was followed by a second-round
PCR using the first-round PCR product as the template and Mar2 (5-TAGC
GACGCCATCTATGTGTC-3) and Arb2 (5-GGCCACGCGTCGACTAGTA
C-3) as the primers. PCR products were sequenced using the primer Mar2,
which allows sequencing outward across the insertion junction of TnKGL3. A
BLAST search of DNA sequences was done against the whole genome of
N16961 available in public databases.
Construction of lacZ transcriptional fusions and LacZ assay. To construct
single-copy lacZ transcriptional fusions, DNA fragments containing the pro-
moter region of ald (representing the first gene of the cluster, VC1589) or als
(representing the second gene, VC1590) were flanked with EcoRI and KpnI
restriction sites and ligated with an EcoRI-KpnI digest of pVIK112 (20) con-
taining the promoterless lacZ structural gene with its own ribosomal binding site.
E. coli BW20767, harboring each transcriptional lacZ fusion, was used as a donor
strain in biparental matings. -Galactosidase activity was measured as described
previously (35).
Quantification of glycolysis metabolites in the culture supernatants. The
glucose level remaining in the media was measured using a QuantiChrom glu-
cose assay kit (Bioassay Systems, Hayward, CA). The acetoin level was quanti-
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Serogroup/biotype Relevant genotype or description Reference or source
Strains
V. cholerae
N16961 O1/El Tor Smr lacZ 8
O395 O1/classical Smr lacZ 8
CA401 O1/classical 6
569B O1/classical Smr 6
MO10 O139 Smr 51
AM19226 Non-O1, non-O139 Smr 9
V52 Non-O1, non-O139 Smr 39
SSY01 N16961, als::TnKGL3 This study
SSY02 N16961, ald This study
SSY03 N16961, VC1591 This study
SSY04 O395, pgi::TnKGL3 This study
E. coli
DH5 supE44 lacU169 (80dlacZM15) hsdR17 recA1 endA1
gyrA96 thi-1 relA1
13
SM10pir Kmr thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu pir 5
BW20767 Km::Tn7 leu-63::IS10 recA1 creC510 hsdR17 endA1 zbf-5
uidA(Mlu1)::pir thi
34
P. aeruginosa
PAO1 14
Plasmids
pWM91 sacB suicide vector, Apr 34
pTnKGL3 Suicide vector bearing TnKGL3, Cmr Kmr This study
pVIK112 Suicide vector for lacZ reporter fusion, Kmr 20
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tatively measured as described previously (43). Levels of two organic acids (lactic
acid and acetic acid) were determined using an assay kit (Megazyme Interna-
tional Ireland Ltd., Wicklow, Ireland) by following the instructions provided by
the manufacturer.
Infant mouse colonization assay. For the infant mouse colonization assay,
	105 to 106 total CFU was inoculated intragastrically into an infant mouse (	5
to 6 days old; Charles River Breeding Laboratories) as described previously (52).
After a period of colonization, intestinal homogenates were collected and viable
cells were enumerated by spreading serial diluents on LB agar containing strep-
tomycin (for total bacterial count) or streptomycin-kanamycin (for SSY01
count). Strains to be inoculated were grown in LB to an optical density at 600 nm
(OD600) of 	0.5 and diluted 500-fold in LB or LB plus 2.5% glucose (LBG)
before inoculation. Competitive indices were calculated by dividing the output
CFU of SSY01 by the output CFU of N16961.
Microscopic examination of biofilms. For examination of biofilm architecture
and cell viability, an eight-chambered coverslip system (Lab-Tek Inc., Campbell,
CA) was used. LB (0.4 ml) was inoculated with 4 l of overnight-grown LB
starter culture. After 24 h of static growth at 37°C, biofilms were washed two
times with modified artificial seawater (MASW) (234 mM NaCl, 27.5 mM
MgSO4, 1.5 mM NaHCO3, 4.95 mM CaCl2, 5.15 mM KCl, 18.7 mM NH4Cl, pH
7.2) and treated with MASW containing 0% or 1% N-acetyl-D-glucosamine
(NAG) for 24 h. Biofilms were stained with 0.2 ml of a LIVE/DEAD BacLight
(Molecular Probes, Inc., Eugene, OR) bacterial viability stain for 15 min. Images
were acquired on a Nikon TE200 inverted microscope with a C1 laser scanning
confocal unit attached (Nikon Instruments, Inc., Melville, NY). For two-color
images, samples were scanned sequentially at 488 and 546 nm. Syto-9 (green
fluorescence) was detected through a 505- to 530-nm band-pass filter, and pro-
pidium iodide (red fluorescence) was detected through a 560-nm long-pass filter;
these were presented in two channels of a 512- by 512-pixel, 8-bit image. Meta-
Morph (Molecular Device Corp., Sunnyvale, CA) imaging software was used to
condense 25 serial stacks of confocal images.
RESULTS
Classical biotype V. cholerae strain O395 loses viability dur-
ing in vitro culture in the presence of glucose. To examine the
effect of glucose on growth of two biotypes of O1 V. cholerae,
the El Tor strain N16961 and the classical strain O395 were
grown in LB containing 0% or 1% glucose. We chose N16961
because its genomic sequence has been determined and thus it
is a well-characterized seventh-pandemic El Tor strain and
O395 because it has been investigated extensively in previous
studies. As shown in Fig. 1A, N16961 grew better in a medium
supplemented with glucose (OD600 of 	8.0 versus 	6.0). Con-
sistently, 	10-fold more viable cells were detected in the glu-
cose-supplemented culture than in the control, unsupple-
mented medium (Fig. 1C). In contrast, O395 showed a
significant growth defect under the same culture conditions. In
the presence of 1% glucose, bacterial growth virtually ceased
after 4 h and reached an OD600 of only 	1.8 after 8 h of
culture (Fig. 1B). Importantly, no viable bacteria were recov-
ered after 15 h of culture with 1% glucose (Fig. 1C). The loss
of viability was also observed in the culture medium containing
glucose levels as low as 0.3% or other medium carbohydrates,
such as sucrose (data not shown). Since V. cholerae is highly
susceptible to acidic pH (33, 52) and glucose fermentation
leads to the production of organic acids, such as lactic acid and
acetic acid, we monitored pH change in culture media. After a
small drop to 	6.0, medium pH rose to 
8.0 with time in the
glucose-supplemented culture of N16961. O395, however,
acidified culture media persistently, and after 8 h, the pH
dropped to about 	5.0 (Fig. 1D). When O395 was grown in
pH-buffered media (pH 8.0) supplemented with 1% glucose,
the pH drop was minimized and the loss of viability was not
detected (data not shown). Thus, metabolism of glucose by
O395 resulted in the acidification of the growth medium and
killing of cells at low pH in glucose-supplemented but not
unsupplemented medium. Collectively, these data suggest that
glucose exerts a differential effect on the growth and viability of
strains of V. cholerae depending on biotype.
O139 and non-O1/non-O139 strains revealed a glucose
growth phenotype identical to that of N16961. As shown in Fig.
2, two other classical strains, CA401 and 569B, also exhibited
a glucose growth phenotype identical to that of O395, suggest-
ing that the glucose-dependent pH drop may occur universally
among classical biotype strains. In contrast, growth of strain
MO10 (O139 serogroup) in the presence of glucose was en-
hanced, further confirming previous reports that pathogenic
O139 strains are closely related to pandemic O1 El Tor biotype
strains (2, 4, 18, 22). Two non-O1/non-O139 strains, AM19226
(8) and V52 (39), were also identical to N16961 or MO10 as far
as glucose growth phenotype (Fig. 2). In addition, two other
gram-negative bacteria, Pseudomonas aeruginosa PAO1 and
Escherichia coli DH5, grew better or equally well in the pres-
ence versus absence of glucose, respectively. These results in-
dicate that glucose-induced loss of viability occurs uniquely in
V. cholerae O1 classical biotype strains.
The 2,3-butanediol fermentation pathway is essential for
maintaining viability in glucose-containing media. To identify
the molecular basis accounting for such dramatic differences in
glucose metabolism, a random transposon insertion mutant
library of N16961 was constructed to screen for mutants that
exhibit glucose growth phenotypes identical to that of O395.
FIG. 1. Killing of V. cholerae O1 classical biotype by glucose-in-
duced pH drop. (A and B) Aerobic flask culture of El Tor biotype
strain N16961 and classical biotype strain O395. Bacteria were cultured
in LB containing 0% (LB) or 1% (LBG) glucose, and growth was
monitored by measuring OD600. (C) Loss of viability in the glucose-
supplemented culture of O395. To enumerate viable cells, 10 l of
serial dilutions (	103 to 107) was spotted on LB agar plates and
incubated at 37°C overnight. The left and right sides of each plate
represent bacteria grown in LB and LBG, respectively, for 15 h.
(D) pH change of the culture supernatants in the culture of N16961 or
O395. Bacteria were grown in LB plus 1% glucose.
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Because these glucose-dependent growth phenotypes were re-
lated to acid production, we took advantage of phenol red, a
pH-dependent color indicator, which is pink or yellow under
basic and acidic conditions, respectively. Consistent with the
results in Fig. 1D, strains N16961 and O395 growing on such
phenol red pH indicator plates substituted with glucose were
pink and yellow in color, respectively (Fig. 3A). We isolated an
N16961 transposon mutant (strain SSY01) that acidified the
culture media and was yellow on the same pH indicator plate
(Fig. 3A). As expected, this mutant also lost viability due to the
glucose-induced pH drop, as observed for the classical biotype
strain O395 (data not shown). The gene disrupted by the trans-
poson insertion carried by SSY01 was determined to be als
(VC1590), encoding acetolactate synthase (Als). Als is in-
volved in the 2,3-butanediol fermentation pathway, catalyzing
the first step in the pathway from pyruvate to 2,3-butanediol
(Fig. 3B). To support the conclusion that synthesis of 2,3-
butanediol could block production of acidic metabolites in the
presence of glucose, we constructed clean deletion mutants of
VC1589 and VC1591, which are deficient in acetolactate de-
carboxylase (Ald) and oxidoreductase, respectively. The strain
carrying the in-frame deletion of ald (SSY02) showed a phe-
notype identical to that of SSY01 in growth and pH change
(Fig. 3C), further supporting an essential role for the 2,3-
butanediol pathway in maintaining viability in media contain-
ing glucose. Interestingly, the VC1591 mutant SSY03, which is
not able to convert acetoin to 2,3-butanediol, still acidified
culture media but not to the same extent as the other two
mutants (SSY01 and SSY02) (Fig. 3C). This suggests that (i)
FIG. 2. Glucose growth phenotypes of various V. cholerae strains.
Seven V. cholerae strains and two control gram-negative strains were
grown in LB or LBG. The OD600 of each culture at 15 h is shown. *, no
viable cells were detected in these cultures; **, the increase in growth in
the presence versus absence of glucose is statistically significant (P 
0.05).
FIG. 3. Role of the 2,3-butanediol fermentation pathway in maintaining viability and effect of each mutation on pH drop and growth in the
presence of glucose. (A) Identification of an N16961 mutant that acidified culture medium in the presence of glucose. Color changes of overnight
growth of N16961, O395, SSY01, and SSY04 on a pH indicator plate (see Materials and Methods). (B) Biochemical pathway of 2,3-butanediol
fermentation. Pyruvate, a glycolysis product, is fermented to 2,3-butanediol with intermediates that include acetolactate and acetoin. Enzymes
involved in each step are Als, Ald, and oxidoreductase. Mixed acid fermentation leading to the production of organic acids is also shown on the
right. Mutants of VC1590, VC1589, and VC1591 are named SSY01, SSY02, and SSY03, respectively. EtOH, ethanol. (C) Bacterial growth and pH
change profiles. Experimental conditions were identical to those described in the legend for Fig. 1. Bacteria were grown in LBG for 8 h.
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all participating enzymes should be functional to prevent the
pH drop and (ii) the first two steps play a more important role
in reducing the availability of pyruvate towards the mixed acid
fermentation pathway. The SSY03 mutant maintained viability
in the culture with 1% glucose, while SSY01 and SSY02 lost
their viabilities (data not shown). We then asked whether a
mutant of O395 defective in glycolysis could survive the glu-
cose-supplemented culture. A transposon insertion mutant of
strain O395 (SSY04) in the gene pgi, encoding phosphoglucose
isomerase (VC0374), which mediates the second step of gly-
colysis, indeed could not acidify the culture media containing
glucose (Fig. 3A) and thus maintained viability in the presence
of glucose (data not shown). These data confirm that glucose
metabolism through the glycolytic pathway causes classical bio-
type strains, such as O395, to acidify growth media containing
glucose. These results also suggest that the classical biotype of
V. cholerae O1 may possess an inherent defect in the 2,3-
butanediol fermentation pathway.
Glucose derepresses transcription of genes involved in the
2,3-butanediol pathway in El Tor strain N16961 but not in
classical strain O395. Examination of the coding sequences of
ald and als in strains N16961 and O395 revealed no obvious
defects in these two structural genes in strain O395. Accord-
ingly, we asked whether the lack of a functional 2,3-butanediol
fermentation pathway in strain O395 was caused by a biotype-
specific difference in transcriptional expression of genes encod-
ing enzymes in the pathway. To test this, we monitored the
promoter activities of ald and als by constructing lacZ reporter
gene fusions to these two genes. The constructs were inte-
grated onto the chromosomes of lacZ-defective derivatives of
N16961 and O395. -Galactosidase activity was monitored in
media supplemented with or without glucose (Fig. 4). In strain
O395, extremely low levels of LacZ were detected for both
reporter strains, irrespective of the presence or absence of
added medium glucose (Fig. 4), suggesting that transcription of
these genes was very low in O395. In contrast, ald promoter
activity was increased 	50-fold in the presence versus absence
of glucose for N16961 (Fig. 4). This suggests that the 2,3-
butanediol fermentation pathway is highly induced by the pres-
ence of excess glucose in this El Tor biotype strain. Curiously,
we observed that glucose caused only an 	2.5-fold increase of
als promoter activity in N16961, suggesting that regulation of
the second gene (ald) in the pathway from pyruvate to 2,3-
butanediol accounts for the metabolic differences between
N16961 and O395.
Strain N16961 maintains viability in the glucose-supple-
mented cultures by producing a high level of acetoin, a neutral
fermentation product, and by suppressing the accumulation of
organic acids. To better understand the discrepancy between
glucose metabolism in classical versus El Tor biotypes, we
quantitatively monitored glucose levels and three different end
products (i.e., acetoin, lactic acid, and acetic acid) of the glu-
cose fermentation in the culture media (Fig. 3B). As shown in
Fig. 5A, strain N16961 consumed glucose completely in 6 h. In
contrast, only 	15% or 	30% of the initial glucose was con-
sumed by strain O395 or SSY01, respectively, in 8 h. This
result, in part, accounts for our initial observation that N16961
growth was enhanced in the presence of glucose (Fig. 1A). The
ability to produce acetoin, one of two equilibrium end products
of the 2,3-butanediol fermentation pathway, has been one of
the major parameters for biotyping of classical and El Tor
strains (21). As expected, high levels of acetoin were detected
in cultures of N16961 supplemented with glucose, whereas no
acetoin was produced in strain O395 or SSY01 (Fig. 5B). How-
ever, we were astonished to find that after 8 h of growth on
glucose, N16961 produced 	22.5 mM of acetoin, a level that is
	40% of the initial glucose concentration (1%, 55.6 mM). In
contrast, lactic and acetic acid concentrations continued to rise
in cultures of strain O395 or the SSY01 mutant (Fig. 5C and D)
during the same period of acetoin production by N16961. Lac-
FIG. 4. Transcriptional regulation of genes involved in the 2,3-
butanediol pathway in classical and El Tor biotypes. Shown are the
organization of genes encoding enzymes in this pathway and the pro-
moter activities of two potential promoters present in this cluster.
Bacterial strains harboring single-copy ald-lacZ or als-lacZ fusions
were assayed for -galactosidase activity in triplicate, and means 
standard errors of the means are presented.
FIG. 5. Time profiles of metabolites in the glucose-supplemented
culture. Three bacterial strains, N16961, O395, and SSY01, were
grown in LB containing 1% glucose for 8 h. Levels of glucose, acetoin,
lactic acid, and acetic acid in culture supernatants were measured as
described in Materials and Methods and plotted with respect to time.
In panel B, lines for O395 and SSY01 are superimposed.
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tic acid levels, in particular, were dramatically increased in the
culture media of the SSY01 mutant compared to those of its
parental strain and O395 (Fig. 5C). These data are similar to
the observation that higher glucose levels were consumed in
SSY01 than in strain O395, suggesting that glucose consump-
tion drives lactic acid accumulation in both of these strains
(Fig. 5A and C). Acetic acid levels were significantly higher
than those of lactic acid during the entire growth period (Fig.
5C and D), suggesting that the pH drop is mainly due to acetic
acid. Importantly, strain N16961 was capable of minimizing the
accumulation of both lactic and acetic acids. Acetic acid and
lactic acid were produced in the early logarithmic phase of
growth, while levels decreased to baseline at 	6 h (Fig. 5C and
D). Taken together, these results suggest that El Tor strain
N16961 possesses the metabolic potential to turn glucose into
acetoin and 2,3-butanediol and keep production of two harm-
ful organic acids to a minimum. This metabolic strategy results
in the full utilization of available glucose, compared to classical
biotype strains, which do not have this capacity.
The N16961 als mutant is defective in colonizing infant
mouse intestine. We have observed previously that classical
biotype strains are less able to colonize the intestines of infant
mice than strains of the El Tor biotype (unpublished observa-
tions). The molecular basis for this was not understood. We
hypothesized that differences in sensitivity to glucose between
classical and El Tor biotypes might account for this difference
in in vivo colonization. The average luminal glucose concen-
tration in the small intestine was previously reported to range
between 0.2 and 48 mM in normally feeding animals, with the
higher concentrations found in the proximal small intestine
(10). Because SSY01 showed a sensitivity to glucose that was
comparable to that of classical strain O395, we tested whether
this mutant strain would have a colonization defect in the
intestines of infant mice. To better evaluate the effect of glu-
cose on in vivo colonization, bacteria were also inoculated into
animals with extra glucose. After 24 h of intestinal growth, the
total CFU of strain N16961 and its isogenic als mutant in-
creased 	20-fold and 	8-fold, respectively (Fig. 6A). When
inoculated with additional glucose,	2-fold more CFU of wild-
type N16961 were recovered. In contrast, the isogenic N16961
als mutant SSY01 showed a statistically significant colonization
defect when inoculated with glucose compared to results when
inoculated without glucose (Fig. 6A). The level of colonization
by SSY01 was 	3-fold (without glucose in the inoculum) or
	42-fold (with glucose in the inoculum) less that of N16961
(Fig. 6A). These data suggest that glucose-mediated toxicity
may still occur in vivo and is enhanced by addition of glucose
to the inoculum.
Based upon these data, we next determined the competitive
index of the SSY01 mutant compared to that of its parental
FIG. 6. Effect of glucose on in vivo colonization of SSY01. (A) Infant mice were individually infected with 2.5  105 CFU (dashed line) of
wild-type N16961 or SSY01. In 24 h, bacteria were recovered from mice and plated on appropriate media for enumeration. Prior to inoculation,
bacterial cells, which were grown in LB to an OD600 of 	0.5, were diluted 500-fold in fresh LB containing 0% (LB) or 2.5% (LBG) glucose. Six
mice were used for each group, and means  standard errors of the means are presented on a logarithmic scale. For SSY01, the decrease in CFU
upon coinoculation with glucose was statistically significant (*, P  0.05). (B) Infant mice were coinfected with 5  10
5 CFU of each strain. Again,
bacterial cells were diluted in LB or LB containing 2.5% glucose before inoculation. After 24 h of incubation, CFU of each strain was enumerated
and plotted in a linear scale. The competitive index represents the ratio of SSY01 to N16961 recovered after incubation. Ten mice were used for
each infection, and means  standard errors of the means are presented.
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strain. Even without additional glucose in the inoculum, SSY01
was only 	9.4% as competitive as wild-type N16961 (Fig. 6B,
top). When a 1:1 mixture of bacteria was inoculated together
with glucose, the competitive index did not change significantly
(	6.7%, P  0.167 versus glucose-free infection). This was
surprising because N16961 colonized better with extra glucose
whereas colonization of SSY01 was decreased, as shown in Fig.
6A. Interestingly, the total number of viable organisms of both
strains decreased 	2-fold compared with that recovered from
glucose-free infected mice (Fig. 6B, bottom). These results
suggest that the glucose-mediated toxic effect caused by the
mutant may alter the colonization properties of the wild-type
strain in vivo. This would be expected if both strains form
mixed microcolonies or biofilms on the mucosal surface that
then become acidic as a result of in vivo carbohydrate utiliza-
tion by SSY01. Such clumping of V. cholerae on the mucosal
surface has previously been observed with the infant mouse
model (25).
NAG, a monomeric unit of chitin, inhibits the biofilm de-
velopment of classical biotype strain O395. V. cholerae inhabits
aquatic environments and is capable of forming multicellular
communities known as biofilms on the surface of chitin, one of
the most predominant carbohydrate polymers in nature (24,
31, 32). V. cholerae expresses chitinases, and the product of the
action of these enzymes is NAG. We asked whether NAG was
similar to glucose in terms of its differential effect on the
growth of El Tor versus classical biotypes of V. cholerae. We
found that cultures of strain O395 or SSY01, but not cultures
of N16961, produced acid when grown in LB supplemented
with 1% NAG but not in its absence (Fig. 7A). A similar drop
in pH was also observed when each strain was grown with the
hexameric unit of chitin, hexa-N-acetylchitohexaose (data not
shown). These results led us to hypothesize that El Tor biotype
strains of V. cholerae might also have a survival advantage over
strains of classical biotype in the environment, where bacteria
grow as biofilms in association with chitinous surfaces. To test
this hypothesis, we treated routine LB-grown, 1-day-old bio-
films with MASW with or without 1% NAG to assess whether
these treatments would affect biofilm density and/or cell via-
bility. When strains were grown statically to form biofilms in
regular LB media for 1 day, the classical strain O395 developed
a somewhat less dense biofilm than N16961 or SSY01 (Fig. 7B,
FIG. 7. Effect of NAG on biofilm viability. (A) pH change of culture supernatants in the NAG-supplemented culture. Culture conditions were
identical to those described in the legend for Fig. 1D, except for the use of 1% NAG in the media. (B, C, and D) Confocal laser microscopic analysis
of biofilms of N16961, O395, and SSY01. To acquire images, live cells were stained with Syto-9 (green) and dead cells were stained with propidium
iodide (red). Top (x-y plane) views were projected from a stack of 25 images taken at 0.5-m intervals for a total of 12 m. Before staining,
1-day-old biofilms were treated with MASW (see Materials and Methods) containing 0% (top right panel of each set) or 1% (bottom right panel
of each set) NAG for 1 day.
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C, and D, left panels). In each case, biofilm cell density was
invariably decreased when treated with only MASW (Fig. 7B,
C, and D, top right panels), suggesting that bacteria in a bio-
film still require a carbon source to maintain biofilm structure.
Upon treatment with 1% NAG, biofilm cell density was ro-
bustly increased for strain N16961 (Fig. 7B, bottom right
panel). In contrast, there were significantly increased numbers
of dead bacteria in the biofilms of O395 after the same treat-
ment (Fig. 7C, bottom right panel). Similarly, a significant
reduction of biofilm cell density was observed for the biofilm of
SSY01, which also acidified the culture media in the presence
of NAG (Fig. 7D, bottom right panel). The decreased cell
density in these biofilms was likely due to the detachment of
dead bacteria from the biofilm as a result of glucose-induced
acidification of the biofilm. Collectively, these results suggest
that El Tor biotype strains are more capable than classical
biotype strains of propagating and maintaining themselves in
aquatic environments through utilization of chitin as a carbon
and energy source.
DISCUSSION
One of the most long-standing mysteries in cholera epide-
miology is the mechanism(s) by which the classical biotype of
V. cholerae was replaced by the seventh-pandemic El Tor bio-
type as the cause of epidemic and endemic cholera worldwide.
This process began in 1961 and was virtually complete a decade
later. While there were reports of the occasional isolation of
the classical strain in parts of rural Bangladesh as late as the
mid-1980s, current information suggests that even these strains
are actually “hybrid” strains with characteristics of both the
seventh-pandemic El Tor clone and classical strains. Thus, it is
quite possible that the emergence of the seventh-pandemic El
Tor clone has resulted in the extinction of strains of the clas-
sical biotype on a global scale (37). The molecular and ecolog-
ical events that led to this change in the epidemiology of
cholera remain a mystery despite the accumulation of many
new facts about the molecular differences between these bio-
types. For example, a recent comparative genomic study re-
vealed that classical biotype strains are missing 	22 genes
compared to seventh-pandemic El Tor strains, with most of
these genes located on two chromosomal islands (8). Among
the phenotypic and genetic factors that have been proposed
in the epidemiological shift of biotypes are differences in en-
vironmental fitness (38), susceptibility to lytic vibriophages (30,
49), regulation of virulence gene expression (7, 28, 36), viru-
lence gene content (8), and primary sequence of virulence gene
products (23, 50). In this study, we identified a unique differ-
ence in carbohydrate metabolism between these two biotypes
of V. cholerae and propose that this difference could plausibly
account for the improved evolutionary fitness of the seventh-
pandemic clone versus strains of the classical biotype in both
the host and the aquatic environment.
We have shown that classical biotype O1 strains grow poorly
in media containing high levels of carbohydrates and lose via-
bility in such media due to the glycolysis-dependent production
of organic acids and the resultant acidification of the medium.
In contrast, O1 strains of the El Tor biotype grow better in the
presence of excess carbohydrates and avoid acidification of
their growth medium by production of the neutral fermenta-
tion end products acetoin and 2,3-butanediol (Fig. 1 to 3).
Furthermore, other V. cholerae strains of recent clinical or
environmental importance (i.e., O139 and non-O1/non-O139
serogroups) show the same phenotype as the El Tor biotype of
O1 V. cholerae in terms of carbohydrate metabolism.
A molecular basis responsible for this dramatic difference
was identified by a simple genetic screen (Fig. 3). 2,3-Butane-
diol fermentation is a highly conserved fermentation pathway
present in many bacterial species and has recently been shown
to be important for maintaining viability under carbohydrate-
rich growth conditions in V. cholerae (27). Early physiological
and biochemical characterization of this pathway in Entero-
bacter aerogenes and Klebsiella terrigena revealed that the pro-
duction of 2,3-butanediol is enhanced under acidic and/or an-
aerobic growth conditions (3, 17). Consistent with these
findings, an acetoin level was not detected until the medium
pH dropped to 	6.0 in the glucose-supplemented culture of
N16961 (Fig. 1D and 5B). Most importantly, no further pH
drop was observed until the exogenously added glucose was
completely consumed (Fig. 5A), indicating that 2,3-butanediol
synthesis is indispensable to prevent hyperacidification under
such carbohydrate-rich growth conditions. Our data also
showed that pH homeostasis in El Tor biotype strains was
achieved by active degradation of acetate and lactate (Fig. 5C
and D).
In V. cholerae, production of virulence factors is strongly
influenced by environmental signals, such as pH and temper-
ature. It is not clearly defined, however, why virulence gene
expression, especially in strains of the classical biotype, is in-
creased at pH 6.5 and 30°C (48). Recently, an intriguing link
between virulence and energy metabolism in V. cholerae has
been proposed by Kovacikova and colleagues (27). In this
work, AphA, a transcriptional activator for the tcpPH pro-
moter, was reported to repress the expression of genes for
2,3-butanediol synthesis by directly binding to the transcrip-
tional start site of alsD (VC1589), the first gene in the cluster
(27). In the same study, it was also shown that expression of
biosynthetic genes was derepressed by AlsR (VC1588), which
becomes activated upon acidification. This result might (i)
suggest that AphA, coupled with AlsR, can reciprocally regu-
late virulence gene expression and 2,3-butanediol synthesis in
response to pH change and (ii) provide a possible explanation
for why the virulence gene expression is elevated at pH 6.5 (29,
48). Interestingly, when mutation of the aphA gene was intro-
duced, expression of the tcpP gene was significantly decreased
(
10-fold) in O395, whereas only a twofold decrease was ob-
served to occur in C6706, another El Tor biotype strain (29).
This suggests that AphA-dependent gene regulation may occur
more actively in strains of classical biotype and, thus, gene
expression for 2,3-butanediol synthesis is suppressed to a
higher extent in classical biotype strains than in El Tor. Addi-
tional experiments are necessary in order to understand the
different gene regulation by AphA in the two biotypes.
We also obtained evidence that 2,3-butandediol synthesis
confers El Tor biotypes a survival advantage in vivo during
infection. The N16961 als mutant (SSY01), which showed an in
vitro growth phenotype in control media identical to that of its
parental strain, was defective in colonizing the intestines of
infant mice (Fig. 6). Because the colonization defect of this
mutant became more severe when the inoculum was “spiked”
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with added glucose, we postulate that a glucose-mediated toxic
effect in classical biotypes still occurs in vivo and that the
functional 2,3-butanediol pathway is required for better colo-
nization in the host intestine.
It is interesting to note that oral rehydration solution (ORS)
containing 20 g/liter glucose (12, 40) is frequently used to treat
the dehydration caused by V. cholerae infection (45, 47). ORS
has been used since the early 1960s, and this period happens to
correspond to the same decade in which the seventh-pandemic
clone emerged and replaced the classical biotype. It is tempting
to speculate that the glucose present in ORS may have con-
tributed to an in vivo selection of El Tor strains, at least in
those patients that were not simultaneously treated with anti-
biotics. Thus, ORS may have been antibacterial for classical
biotype strains that would be sensitive to added glucose but
stimulatory to El Tor biotype strains that actually could utilize
this sugar with no deleterious effects.
Biofilms represent the major V. cholerae growth mode in
aquatic environments (52). Thus, we also examined the role of
2,3-butanediol synthesis in pH homeostasis in planktonic cul-
tures and biofilms growing in the presence of NAG, the end
product of chitin degradation. In planktonic cultures, medium
acidification and resultant cell death were observed for classi-
cal strain O395 and the N16961 als mutant SSY01 in the
presence of NAG (Fig. 7A). Thus, both biotypes can metabo-
lize NAG but 2,3-butanediol synthesis is required to avoid acid
production and killing in planktonic cultures. Upon treatment
with NAG, N16961 biofilms show a dramatic increase in bio-
film cell density (Fig. 7B). In contrast, a decrease in cell via-
bility and/or cell density was detected in biofilms of two sensi-
tive strains, O395 and SSY01 (Fig. 7C and D). These data
suggest that (i) El Tor strains growing as a biofilm can utilize
NAG as a carbon and energy source and (ii) the utilization of
chitin, a ubiquitous carbohydrate in the aquatic milieu, may
exert a harmful effect on the survival of classical biotype strains
when they grow in biofilms. Recently, it has been reported that
V. cholerae becomes competent for DNA uptake and transfor-
mation when exposed to chitin (31), suggesting that growth on
chitinous surfaces may be a common adaptation of this species
and tied intimately to its genetic variability and evolution.
Accordingly, it is interesting to note that classical strains are far
less genetically diverse than non-O1, non-O139 strains (9). As
noted earlier, non-O1 and non-O139 strains are similar to El
Tor O1 strains in terms of carbohydrate metabolism (i.e., they
produce 2,3-butanediol) and these strains are also quite unique
in that they have acquired novel virulence loci, such as type III
secretion, by horizontal transfer (9). Resistance to chitin-in-
duced acidification of biofilms may be responsible for the
higher levels of diversity seen in these strains driven by chitin-
induced DNA transformation and recombination.
It has also been suggested that the displacement of the
classical biotype by El Tor may be due to the ability of El Tor
biotype strains to grow better in foods, such as cooked rice
(26). Because the infectious dose of V. cholerae is known to be
quite high for humans with normally acidic stomach contents,
transmission via contaminated food may be more important
than transmission through contaminated water alone. Re-
cently, the results of mathematical modeling of phage-medi-
ated modulation of cholera epidemics have provided compel-
ling evidence that amplification of V. cholerae in food sources
may an important rate-limiting step in cholera epidemics (16).
Our results suggest that the El Tor biotype might replicate in
carbohydrate-rich foodstuffs (e.g., rice) better than the classi-
cal biotype and that this too could have contributed to the
demise of the classical biotype if food-mediated amplification
of V. cholerae is a necessary step in the generation and prop-
agation of cholera epidemics.
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